AQR Capital Management
ZVRA icon

AQR Capital Management’s Zevra Therapeutics ZVRA Stock Holding History

AQR Capital Management’s Portfolio ZVRA Stock Details ZVRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$745K Sell
79,915
-101,214
-56% -$912K ﹤0.01% 2920
2025
Q4 		$1.62M Buy
181,129
+28,818
+19% +$273K ﹤0.01% 2259
2025
Q3 		$1.45M Buy
+152,311
New +$1.53M ﹤0.01% 2199
2025
Q1 		– Sell
-11,728
Closed -$97.8K – 3208
2024
Q4 		$97.8K Buy
+11,728
New +$100K ﹤0.01% 2766
2022
Q3 		– Sell
-107,341
Closed -$479K – 2341
2022
Q2 		$479K Sell
107,341
-102,759
-49% -$468K ﹤0.01% 1702
2022
Q1 		$1.06M Buy
210,100
+149,668
+248% +$952K ﹤0.01% 1512
2021
Q4 		$526K Sell
60,432
-40,378
-40% -$360K ﹤0.01% 1808
2021
Q3 		$941K Buy
+100,810
New +$1.02M ﹤0.01% 1574

Other funds holding ZVRA

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $1.6B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $488M AUM 327.32% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return